基于昆的化合物可以抑制作用于DNA的各种酶
Jujun Zhou1, Qin Chen1, Ren Ren1
1Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
新的林基化合物显示出作为DNA低甲基化剂的前景. 这些非核酸抑制剂向DNA甲基转移酶,为各种疾病的现有疗法提供了潜在的替代方案.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 生物化学 生物化学
- 药用化学 医学化学
背景情况:
- 基因甲基化是调节基因表达的关键表观遗传机制.
- 目前的低甲基化剂面临着毒性挑战.
- 需要新的非核酸抑制剂来克服基于核酸的药物的局限性.
研究的目的:
- 为了识别和描述DNA甲基转移酶的新型非核酸抑制剂.
- 探索基于氨酸的类似物作为DNA低甲基化治疗剂的潜力.
- 研究这些化合物的作用机制和细胞效应.
主要方法:
- 合成和表征15种基于类素的类似物.
- 对人类DNMT1和Clostridioides difficile CamA进行酶抑制测定.
- 通过小沟,使用干到CAMA结合DNA的DNA结合研究.
- 基于细胞的测试来评估DNA损伤反应和p53激活.
主要成果:
- 化合物9和11表现出对DNMT1和Cama的低微分子抑制功效.
- 发现化合物9和11与CAMA结合的DNA进行介质,诱导构造变化.
- 一些类似物体对其他与DNA相互作用的酶,包括聚合酶和葡萄糖酶,表现出抑制活性.
- 化合物11触发了癌细胞中通过p53激活的DNA损伤反应.
结论:
- 基诺林类类似物代表了一种新型的非核酸DNA甲基转移酶抑制剂.
- DNA间隙是抑制DNA甲基转移酶的一个可行的机制.
- 化合物11通过诱导DNA损伤反应,显示出作为抗癌剂的潜力.
- 对这些化合物的进一步研究可能会导致针对表观遗传失调的新疗法策略.
更多相关视频
05:32Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
Published on: May 12, 2023
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
相关概念视频
Enzyme Inhibition
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Gene Regulation in Microbial Communities: Quorum Sensing
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
